合成路线1
该中间体在本合成路线中的序号:
(VII) Reaction of the dicarboxylic acid (I) with thionyl chloride in hot toluene gives the di-acid chloride (II). Treatment of (II) with Cl2 in CH2Cl2 gives the sulfenyl chloride (III), which upon reaction with NH4OH affords the benzisothiazole (IV). Chlorination of (IV) in heat POCl3 yields the chlorobenzisothiazole (V). Reaction of (V) and piperazine (VI) in excess molten pipeazine gives the monosubstituted piperazine (VII). Reaction of (VII) with the dibromide (VIII) in refluxing ethanol yields the spiroquaternary (IX). Finally, BMY-13859-1 is obtained by treatment of (IX) with the glutarimide (X) in refluxing xylene followed by treatment with HCl in isopropanol.
【1】
Eison, M.S.; Taylor, D.P.; New, J.S.; Minielli, J.L.; BMY-13859. Drugs Fut 1985, 10, 9, 731.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10404 |
Ethyl vanillin; 3-Ethoxy-4-hydroxybenzaldehyde
|
121-32-4 |
C9H10O3 |
详情 | 详情
|
(II) |
10405 |
2-Chloro-2-[3-ethoxy-4-(pentyloxy)phenyl]acetonitrile
|
|
C15H20ClNO2 |
详情 |
详情
|
(III) |
28018 |
2-(chlorosulfanyl)benzoyl chloride
|
|
C7H4Cl2OS |
详情 |
详情
|
(IV) |
16278 |
1,2-benzisothiazol-3(2H)-one; 1,2-Benzisothiazolin-3-one
|
2634-33-5 |
C7H5NOS |
详情 | 详情
|
(V) |
16279 |
3-chloro-1,2-benzisothiazole
|
|
C7H4ClNS |
详情 |
详情
|
(VI) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(VII) |
16280 |
3-piperazino-1,2-benzisothiazole; 1,2-Benzisothiazole-3-(1-piperazinyl)
|
87691-87-0 |
C11H13N3S |
详情 | 详情
|
(VIII) |
11883 |
1,4-Dibromobutane; 1,4-Butylene bromide
|
110-52-1 |
C4H8Br2 |
详情 | 详情
|
(IX) |
28019 |
8-(1,2-benzisothiazol-3-yl)-8-aza-5-azoniaspiro[4.5]decane bromide
|
|
C15H20BrN3S |
详情 |
详情
|
(X) |
28020 |
8-azaspiro[4.5]decane-7,9-dione
|
1075-89-4 |
C9H13NO2 |
详情 | 详情
|
合成路线2
该中间体在本合成路线中的序号:
(VIII) This compound can be obtained by two related ways:
1) The reaction of cis-octahydroisobenzofuran-1,3-dione (I) with ammonia in water at 180-90 gives cis-octahydro-1H-isoindole-1,3-dione (II), which is alkylated with 1,4-dibromobutane (III) and K2CO3 in refluxing acetone to yield cis-2-(4-bromobutyl)octahydro-1H-isoindole-1,3-dione (IV). The condensation of (IV) with piperazine (V) in refluxing toluene affords cis-2-(4-piperazinobutyl)octahydro-1H-isoindole-1,3-dione (VI), which is finally condensed with 3-chloro-1,2-benzisothiazole (VII) and K2CO3 in refluxing toluene.
2) The condensation of benzisothiazole (VII) with piperazine (V) by heating at 120 C gives 3-piperazino-1,2-benzisothiazole (VIII), which is then condensed with isoindole (IV) by means of K2CO3 and KI in hot DMF.
3) The 3-chloro-1,2-benzisothiazole (VII) is obtained as follows: The reaction of 2,2'-dithiobenzoic acid (IX) with refluxing SOCl2 gives the corresponding acyl chloride (X), which by treatment with methylamine in THF is converted into the diamide (XI). The reaction of (XI) with PCl5 in refluxing benzene affords 3-chloro-2-methyl-1,2-benzisothiazolium chloride (XII), which is finally heated in refluxing 1,2-dichlorobenzene to give (VII).
【1】
Ishizumi, N.; Antoku, F.; Maruyama, I.; Kojima, A. (Sumitomo Pharmaceuticals Co., Ltd.); Imide derivs., their production and use. EP 0196096; ES 8800219; JP 1987123179; JP 1987277355; JP 1987277356; US 4745117 .
|
【2】
Prous, J.; Castaner, J.; SM-9018. Drugs Fut 1991, 16, 2, 122.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
27329 |
(3aR,7aS)hexahydro-2-benzofuran-1,3-dione
|
13149-00-3 |
C8H10O3 |
详情 | 详情
|
(II) |
31245 |
(3aR,7aS)hexahydro-1H-isoindole-1,3(2H)-dione
|
7506-66-3 |
C8H11NO2 |
详情 | 详情
|
(III) |
11883 |
1,4-Dibromobutane; 1,4-Butylene bromide
|
110-52-1 |
C4H8Br2 |
详情 | 详情
|
(IV) |
31246 |
(3aR,7aS)-2-(4-bromobutyl)hexahydro-1H-isoindole-1,3(2H)-dione
|
|
C12H18BrNO2 |
详情 |
详情
|
(V) |
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(VI) |
31247 |
(3aR,7aS)-2-[4-(1-piperazinyl)butyl]hexahydro-1H-isoindole-1,3(2H)-dione
|
|
C16H27N3O2 |
详情 |
详情
|
(VII) |
16279 |
3-chloro-1,2-benzisothiazole
|
|
C7H4ClNS |
详情 |
详情
|
(VIII) |
16280 |
3-piperazino-1,2-benzisothiazole; 1,2-Benzisothiazole-3-(1-piperazinyl)
|
87691-87-0 |
C11H13N3S |
详情 | 详情
|
(IX) |
20404 |
2-[(2-carboxyphenyl)disulfanyl]benzoic acid; 2,2'-Dithiodibenzoic acid
|
119-80-2 |
C14H10O4S2 |
详情 | 详情
|
(X) |
20405 |
2-[[2-(chlorocarbonyl)phenyl]disulfanyl]benzoyl chloride
|
|
C14H8Cl2O2S2 |
详情 |
详情
|
(XI) |
31248 |
N-methyl-2-([2-[(methylamino)carbonyl]phenyl]disulfanyl)benzamide
|
2527-58-4 |
C16H16N2O2S2 |
详情 | 详情
|
(XII) |
31249 |
3-chloro-2-methyl-1,2-benzisothiazol-2-ium chloride
|
|
C8H7Cl2NS |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(VII) Wolff-Kishner reduction of 6-chloroisatin (I) gives 6-chlorooxindole (II), which is treated with chloroacetyl chloride under Friedel-Crafts conditions to yield 5-chloroacetyl-6-chlorooxindole (III). The ketone (III) is reduced using triethylsilane in trifluoroacetic acid to produce 6-chloro-5-(2-chloroethyl)oxindole (IV). 1,2-Benzisothiazolin-3-one (V) is converted to 3-chloro-1,2-benzisothiazole (VI) using phosphorus oxychloride and is then condensed with piperazine to provide 1-(1,2-benzisothiazol-3-yl)piperazine (VII). Finally, intermediate (VII) is alkylated by compound (IV) in the presence of sodium carbonate in water and is converted to the salt with aqueous hydrochloric acid.
【1】
Lowe, J.A. III; Nagel, A.A. (Pfizer Inc.); Piperazinyl-heterocyclic cpds. US 4831031 .
|
【2】
Bowles, P. (Pfizer Inc.); Process for preparing aryl piperazinyl-heterocyclic cpds. EP 1029861; JP 1994184143; US 5206366 .
|
【3】
Howard, H.R. Jr.; Busch, F.R.; Grobin, A.W.; Leeman, K.R. (Pfizer Products Inc.); Controlled synthesis of ziprasidone and compsns. thereof. WO 0370246 .
|
【4】
Seeger, T.F.; Prakash, C.; Howard, H.R.; Ziprasidone Hydrochloride. Drugs Fut 1994, 19, 6, 560.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10355 |
Diethylenediamine; Piperazine
|
110-85-0 |
C4H10N2 |
详情 | 详情
|
(I) |
16274 |
6-chloro-1H-indole-2,3-dione; 6-Chloroisatin
|
6341-92-0 |
C8H4ClNO2 |
详情 | 详情
|
(II) |
16275 |
6-chloro-1,3-dihydro-2H-indol-2-one
|
56341-37-8 |
C8H6ClNO |
详情 | 详情
|
(III) |
16276 |
6-chloro-5-(2-chloroacetyl)-1,3-dihydro-2H-indol-2-one
|
|
C10H7Cl2NO2 |
详情 |
详情
|
(IV) |
16277 |
6-chloro-5-(2-chloroethyl)-1,3-dihydro-2H-indol-2-one; 5-chloroethyl-6-chloro-1,3-dihydro-1H-indol-2-one-
|
|
C10H9Cl2NO |
详情 |
详情
|
(V) |
16278 |
1,2-benzisothiazol-3(2H)-one; 1,2-Benzisothiazolin-3-one
|
2634-33-5 |
C7H5NOS |
详情 | 详情
|
(VI) |
16279 |
3-chloro-1,2-benzisothiazole
|
|
C7H4ClNS |
详情 |
详情
|
(VII) |
16280 |
3-piperazino-1,2-benzisothiazole; 1,2-Benzisothiazole-3-(1-piperazinyl)
|
87691-87-0 |
C11H13N3S |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
(V) A new synthesis for ziprasidone hydrochloride has been reported:
The condensation of 6-chloroindolin-2-one (I) with bromoacetic acid (II) by means of polyphosphoric acid (PPA) gives 5-(bromoacetyl)-6-chloroindolin-2-one (III), which is reduced with triethylsilane and trifluoroacetic acid to the corresponding 2-bromoethyl derivative (IV). Finally, this compound is condensed with 4-(3-benzisothiazolyl)piperazine (V) by means of Na2CO3 in DMF or isobutyl methyl ketone.
【1】
Howard, H.R.; Lowe, J.A. III, Seeger, T.F.; et al.; 3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agents. J Med Chem 1996, 39, 1, 143.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16275 |
6-chloro-1,3-dihydro-2H-indol-2-one
|
56341-37-8 |
C8H6ClNO |
详情 | 详情
|
(II) |
23660 |
2-Bromoacetic acid
|
79-08-3 |
C2H3BrO2 |
详情 | 详情
|
(III) |
16283 |
5-(2-bromoacetyl)-6-chloro-1,3-dihydro-2H-indol-2-one
|
|
C10H7BrClNO2 |
详情 |
详情
|
(IV) |
16284 |
5-(2-bromoethyl)-6-chloro-1,3-dihydro-2H-indol-2-one
|
|
C10H9BrClNO |
详情 |
详情
|
(V) |
16280 |
3-piperazino-1,2-benzisothiazole; 1,2-Benzisothiazole-3-(1-piperazinyl)
|
87691-87-0 |
C11H13N3S |
详情 | 详情
|
合成路线5
该中间体在本合成路线中的序号:
(I) The condensation of 1-(1,2-benzoisothiazol-3-yl)piperazine (I) with 6-chloro-5-(2-chloroethyl)-2-indolinone (II) in refluxing water or refluxing methyl isobutyl ketone gives the target indolinone derivative.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16280 |
3-piperazino-1,2-benzisothiazole; 1,2-Benzisothiazole-3-(1-piperazinyl)
|
87691-87-0 |
C11H13N3S |
详情 | 详情
|
(II) |
62882 |
6-chloro-5-(3-chloropropyl)-1,3-dihydro-2H-indol-2-one
|
|
C11H11Cl2NO |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(V) The Friedel Crafts condensation of 6-chloroindolin-2-one (I) with 14C labeled 2-chloroacetyl chloride (II) by means of AlCl3 in CS2 gives 6-chloro-5-(2-chloroacetyl)indolin-2-one (III), which is reduced with trimethylsilane in TFA to yield the labeled chloroethyl derivative (IV). Finally, this compound is condensed with 3-(1-piperazinyl)-1,2-benzoisothiazole (V) by means of Na2CO3 in refluxing water to provide the target radiolabeled compound.
【1】
Howard, H.R.; Shenk, K.D.; Smolarek, T.A.; Marx, M.H.; Windels, J.H.; Roth, R.W.; Synthesis of H-3- and C-14-labelled CP-88,059: A potent atypical antipsychotic agent. J Label Compd Radiopharm 1994, 34, 2, 117.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16275 |
6-chloro-1,3-dihydro-2H-indol-2-one
|
56341-37-8 |
C8H6ClNO |
详情 | 详情
|
(II) |
11296 |
2-Chloroacetyl chloride; Chloroacetic chloride
|
79-04-9 |
C2H2Cl2O |
详情 | 详情
|
(II) |
62883 |
2-chloroacetyl chloride
|
|
C2Cl2O |
详情 |
详情
|
(III) |
16276 |
6-chloro-5-(2-chloroacetyl)-1,3-dihydro-2H-indol-2-one
|
|
C10H7Cl2NO2 |
详情 |
详情
|
(III) |
62884 |
6-chloro-5-(2-chloroacetyl)-1,3-dihydro-2H-indol-2-one
|
|
C10H5Cl2NO2 |
详情 |
详情
|
(IV) |
16277 |
6-chloro-5-(2-chloroethyl)-1,3-dihydro-2H-indol-2-one; 5-chloroethyl-6-chloro-1,3-dihydro-1H-indol-2-one-
|
|
C10H9Cl2NO |
详情 |
详情
|
(IV) |
62885 |
6-Chloro-5-(2-chloroethyl)-1,3-dihydro-2H-indol-2-one
|
|
C10H7Cl2NO |
详情 |
详情
|
(V) |
16280 |
3-piperazino-1,2-benzisothiazole; 1,2-Benzisothiazole-3-(1-piperazinyl)
|
87691-87-0 |
C11H13N3S |
详情 | 详情
|
合成路线7
该中间体在本合成路线中的序号:
(V) The nitration of 2,5-dichlorotoluene (I) with HNO3 in H2SO4/AcOH gives 2,5-dichloro-4-methylnitrobenzene (II), which is treated with t-butoxybis(dimethylamino)methane (III) in refluxing THF to yield 2,5-dichloro-4-[2-(dimethylamino)vinyl]nitrobenzene (IV). The condensation of (IV) with 1-(1,2-benzoisothiazol-3-yl)piperazine (V) in AcOH affords the disubstituted piperazine (VI), whose double bond is reduced by means of NaBH(OAc)3 in dichloroethane/AcOH to provide the saturated compound (VII). The condensation of (VII) with dimethyl malonate (VIII) by means of KOH in NMP gives the alkylated malonic ester (IX), which is hydrolyzed and monodecarboxylated with refluxing 3N HCl to yield the phenylacetic acid (X). The esterification of (X) with SOCl2 and methanol affords the methyl ester (XI), which is finally cyclized to the target indolone by reduction of its nitro group with sodium hydrosulfite in refluxing THF/ethanol.
Alternatively, compound (VII) can be condensed with methyl cyanacetate (XII) by means of KOH in NMP to give the alkylated cyanacetic ester (XIII), which is hydrolyzed with refluxing 3N HCl to afford the already reported phenylacetic acid (X).
【1】
Urban, F.J.; et al.; A novel synthesis of the antipsychotic agent ziprasidone. Synth Commun 1996, 26, 8, 1629.
|
【2】
Urban, F.J. (Pfizer Inc.); Processes and intermediates for the preparation of 5-[2-(4-(benzoisothiazol-3-yl)-piperazin-1-yl)ethyl]-6-chloro-1,3-dihydro-indol-2-one. WO 9500510 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
62890 |
1,4-dichloro-2-methylbenzene
|
|
C7H6Cl2 |
详情 |
详情
|
(II) |
62891 |
1,4-dichloro-2-methyl-5-nitrobenzene
|
|
C7H5Cl2NO2 |
详情 |
详情
|
(III) |
21487 |
N-[tert-butoxy(dimethylamino)methyl]-N,N-dimethylamine
|
|
C9H22N2O |
详情 |
详情
|
(IV) |
62892 |
(E)-2-(2,5-dichloro-4-nitrophenyl)-N,N-dimethyl-1-ethenamine; N-[(E)-2-(2,5-dichloro-4-nitrophenyl)ethenyl]-N,N-dimethylamine
|
|
C10H10Cl2N2O2 |
详情 |
详情
|
(V) |
16280 |
3-piperazino-1,2-benzisothiazole; 1,2-Benzisothiazole-3-(1-piperazinyl)
|
87691-87-0 |
C11H13N3S |
详情 | 详情
|
(VI) |
62893 |
3-{4-[(E)-2-(2,5-dichloro-4-nitrophenyl)ethenyl]-1-piperazinyl}-1,2-benzisothiazole
|
|
C19H16Cl2N4O2S |
详情 |
详情
|
(VII) |
62894 |
3-[4-(2,5-dichloro-4-nitrophenethyl)-1-piperazinyl]-1,2-benzisothiazole
|
|
C19H18Cl2N4O2S |
详情 |
详情
|
(VIII) |
19373 |
dimethyl malonate;Methyl malonate;Propanedioic acid dimethyl ester |
108-59-8 |
C5H8O4 |
详情 | 详情
|
(IX) |
62895 |
dimethyl 2-(5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-4-chloro-2-nitrophenyl)malonate
|
|
C24H25ClN4O6S |
详情 |
详情
|
(X) |
62896 |
2-(5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-4-chloro-2-nitrophenyl)acetic acid
|
|
C21H21ClN4O4S |
详情 |
详情
|
(XI) |
62897 |
methyl 2-(5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-4-chloro-2-nitrophenyl)acetate
|
|
C22H23ClN4O4S |
详情 |
详情
|
(XII) |
34458 |
Cyanoacetic acid methyl ester; methyl 2-cyanoacetate
|
105-34-0 |
C4H5NO2 |
详情 | 详情
|
(XIII) |
62898 |
methyl 2-(5-{2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-4-chloro-2-nitrophenyl)-2-cyanoacetate
|
|
C23H22ClN5O4S |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(I) Lurasidone hydrochloride can be synthesized as follows. The condensation of 1-(1,2-benzoisothiazol-3-yl)piperazine (I) with (R,R)-1,2-bis(methanesulfonyloxymethyl)cyclohexane (II) in the presence of potassium carbonate and tetrabutylammonium bisulfate in boiling toluene gives the spiropiperazinium salt (III) (1-3), which is further reacted with bicyclo[2.2.1]heptane-2,3-dicarboximide (IV) by means of potassium carbonate in hot xylene or toluene to yield lurasidone (1-4). Lurasidone base is finally converted to the corresponding hydrochloride salt by treatment with HCl in acetone (5). Scheme 1.
【1】
Yujiro, K., Hisashi, B. (Sumitomo Chem. Co., Ltd.; Sumitomo Pharm. Co., Ltd.). Production method of imido derivative. JP 2003160583. |
【2】
Nobuyuki, A., Hisashi, B. (Sumitomo Chem. Co., Ltd.; Dainippon Sumitomo Pharma Co., Ltd.). Method for producing quaternary ammonium salt. JP 2006169154. |
【3】
Nobuyuki, A., Hisashi, B. (Sumitomo Chem. Co., Ltd.; Dainippon Sumitomo Pharma Co., Ltd.). Method for producing quaternary ammonium salt. JP 2006169155. |
【4】
Saji, I., Muto, M., Tanno, N., Yoshigi, M. (Dainippon Sumitomo Pharma Co., Ltd.). Imide derivatives and their production and use. EP 0464846, JP 5017440, US 5532372, US 5780632. |
【5】
Kakiya, Y., Oda, M. (Sumitomo Pharm. Co., Ltd.). Process for producing imide compound. WO 2005009999. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16280 |
3-piperazino-1,2-benzisothiazole; 1,2-Benzisothiazole-3-(1-piperazinyl)
|
87691-87-0 |
C11H13N3S |
详情 | 详情
|
(II) |
65627 |
(R,R)-1,2-Bis(methanesulfonyloxymethyl)cyclohexane; (1R-trans)-1,2-Cyclohexanedimethanol dimethanesulfonate,; (1R,2R)-1,2-Bis(methanesulfonyloxymethyl)cyclohexane |
186204-35-3 |
C10H20O6S2 |
详情 | 详情
|
(III) |
65628 |
(3aR,7aR)-4'-(1,2-Benzisothiazol-3-yl)octahydrospiro[2H-isoindole-2,1'-piperazinium] methanesulfonate |
186204-37-5 |
C19H26N3S.CH3O3S |
详情 | 详情
|
(IV) |
11173 |
(1R,2S,6R,7S)-4-Azatricyclo[5.2.1.0(2,6)]decane-3,5-dione
|
|
C9H11NO2 |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(IV)
【1】
Zanon J. MartIu O. Ciardella F, et aL. 2007. A process for the preparation of ziprasidone. EP 1787990 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(III) |
16277 |
6-chloro-5-(2-chloroethyl)-1,3-dihydro-2H-indol-2-one; 5-chloroethyl-6-chloro-1,3-dihydro-1H-indol-2-one-
|
|
C10H9Cl2NO |
详情 |
详情
|
(I) |
16276 |
6-chloro-5-(2-chloroacetyl)-1,3-dihydro-2H-indol-2-one
|
|
C10H7Cl2NO2 |
详情 |
详情
|
(II) |
66975 |
6-chloro-5-(2-chloro-1-hydroxyethyl)indolin-2-one |
|
C10H9Cl2NO2 |
详情 | 详情
|
(IV) |
16280 |
3-piperazino-1,2-benzisothiazole; 1,2-Benzisothiazole-3-(1-piperazinyl)
|
87691-87-0 |
C11H13N3S |
详情 | 详情
|
合成路线10
该中间体在本合成路线中的序号:
(I)
【1】
Burgarolas Montero C. Puig Serrano J, Amalot Agtular C, et aL 2006. Condensation process for preparing ziprasidonein the presence of aneutralizing agent. W02006034964 |
【2】
Reddy BP, Reddy KR, Reddy RR, et aL. 2006. Prooess for preparing zipnsidone using silylated intermediates. W0 2006080025 |
【3】
Zetina-Rocha C, Home SE, Buck MA, et aL. 2006. Process for the preparation of ziprasidone (5-{2-[4-(1,2-benzisothiazol-3-yl) -l-pipenzinyl]-6-chloro-l-,3-dihydro-2H-indol-2-one). CA 2487003 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16280 |
3-piperazino-1,2-benzisothiazole; 1,2-Benzisothiazole-3-(1-piperazinyl)
|
87691-87-0 |
C11H13N3S |
详情 | 详情
|
(II) |
16277 |
6-chloro-5-(2-chloroethyl)-1,3-dihydro-2H-indol-2-one; 5-chloroethyl-6-chloro-1,3-dihydro-1H-indol-2-one-
|
|
C10H9Cl2NO |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(V)
【1】
Venkataraman S, RAO UVB, Muwa V, et al. 2006. Process for the preparation of highly pure zipnsidone hydrochloride. US 2006089502 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VI) |
17895 |
2-Amino-2-methylpropane; tert-butylamine; 2-methyl-2-propanamine
|
75-64-9 |
C4H11N |
详情 | 详情
|
(I) |
11296 |
2-Chloroacetyl chloride; Chloroacetic chloride
|
79-04-9 |
C2H2Cl2O |
详情 | 详情
|
(II) |
16275 |
6-chloro-1,3-dihydro-2H-indol-2-one
|
56341-37-8 |
C8H6ClNO |
详情 | 详情
|
(III) |
16276 |
6-chloro-5-(2-chloroacetyl)-1,3-dihydro-2H-indol-2-one
|
|
C10H7Cl2NO2 |
详情 |
详情
|
(IV) |
16277 |
6-chloro-5-(2-chloroethyl)-1,3-dihydro-2H-indol-2-one; 5-chloroethyl-6-chloro-1,3-dihydro-1H-indol-2-one-
|
|
C10H9Cl2NO |
详情 |
详情
|
(V) |
16280 |
3-piperazino-1,2-benzisothiazole; 1,2-Benzisothiazole-3-(1-piperazinyl)
|
87691-87-0 |
C11H13N3S |
详情 | 详情
|
合成路线12
该中间体在本合成路线中的序号:
(VII)
【1】
Howard HR, Shenk KD, Smolarek TA, et aL. 1994. Synthesis of 3H-and 14C-labeled CP-88 059: a potent atypical antipsychotic agent. J Label Comp Radiopharm, 34 (2), 117~125 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VI) |
66979 |
6-chloro-5-(2-chloroethyl)-1,3-dihydro-2H-indol-2-one; 5-chloroethyl-6-chloro-1,3-dihydro-1H-indol-2-one- |
|
C914CH9Cl2NO |
详情 | 详情
|
(VII) |
16280 |
3-piperazino-1,2-benzisothiazole; 1,2-Benzisothiazole-3-(1-piperazinyl)
|
87691-87-0 |
C11H13N3S |
详情 | 详情
|
(I) |
66976 |
2-chloroacetic acid |
|
C14CH3ClO2 |
详情 | 详情
|
(II) |
23811 |
phthaloyl dichloride;1,2-Benzenedicarbonyl dichloride;o-Phthaloyl chloride |
88-95-9 |
C8H4Cl2O2 |
详情 | 详情
|
(III) |
66977 |
2-chloroacetyl chloride;Chloroacetylchloride;Monochloroacetyl chloride |
|
C14CH2Cl2O |
详情 | 详情
|
(IV) |
16275 |
6-chloro-1,3-dihydro-2H-indol-2-one
|
56341-37-8 |
C8H6ClNO |
详情 | 详情
|
(V) |
66978 |
6-chloro-5-(2-chloroacetyl)-1,3-dihydro-2H-indol-2-one |
|
C914CH7Cl2NO2 |
详情 | 详情
|